Description
The Tumor Test Marker YRA385 and YRA391 are part of a comprehensive Tumor Markers Test Kit designed to cater to the advanced needs of oncological diagnostics. Utilizing chemiluminescence immunoassay (CLIA) analyzers, these kits are capable of detecting 18 distinct tumor markers, facilitating the early detection and diagnosis of malignant tumors. This is achieved by identifying elevated tumor marker levels in the blood, a critical step in recognizing various cancer types. The Tumor Test Marker models YRA385 to YRA391 offer versatile testing parameters like AFP, CEA, CA125, CA15-3, CA19-9, and others, ensuring a wide spectrum of diagnosable conditions.
Market Price
Pricing for the Tumor Markers Test Kit, including models YRA385 and YRA391, varies based on the purchase volume and market demand. On average, the cost can range from $500 to $1,500 per kit depending on the specific configuration and the number of tests per box, which come in packages of 50T/Box, 100T/Box, or 24T/Box. For the most accurate pricing tailored to your needs, we encourage you to request a quote through our Kalstein Plus platform.
Frequently Asked Questions
What types of tumors can the YRA385/YRA391 detect?
These kits are versatile and capable of identifying a wide range of common and specific tumor markers such as AFP, CEA, and PSA, related to various cancers including liver, colon, ovarian, and prostate.
Are these kits compatible with all CLIA analyzers?
Yes, the Tumor Test Marker kits are designed to be compatible with standard CLIA analyzers, ensuring integration into most laboratory settings.
Advantages and Disadvantages
Advantages: The primary advantage of the Tumor Test Marker kits is their comprehensive range of detectable markers, enabling early and accurate cancer detection. Furthermore, they are CE and ISO13485 certified, ensuring high standards of quality and reliability.
Disadvantages: While highly effective, these kits require specialized equipment and trained personnel to operate the CLIA analyzers, which may not be feasible in all laboratory settings.
Product Usage in Practice
In real-world applications, the Tumor Test Marker kits are primarily used in medical laboratories and hospitals to assist in the early detection and differentiation of tumors. They play a crucial role during patient screenings, ongoing cancer management, and research endeavors focused on cancer biomarkers.
Recommendations
To maximize the utility of the Tumor Test Marker kits, ensure that they are stored at the recommended temperature of 2-8°C. Regular calibration using the 2/6 points method is advised to maintain accuracy. Additionally, it’s crucial to adhere to the protocols for signal amplification using Alkaline Phosphatase (AP) for consistent results.
Features
– Compatible with chemiluminescence immunoassay analyzers.
– Detection of 18 different tumor markers.
– Key role in early cancer detection.
– Wide testing range including AFP, CEA, and PSA.
– Available in packages of 50T, 100T, and 24T per box.
Technical Specifications
Model | YRA385 | YRA386 | YRA387 | YRA388 | YRA389 | YRA390 | YRA391 |
Tested Parameter | AFP | CEA | CA125 | CA15-3 | CA19-9 | f-PSA | t-PSA |
Analysis Mode | CLIA | ||||||
Package Specification | 50T/BOX, 100T/BOX,24T/BOX | ||||||
Platform | AP(Alkaline Phosphatase) | ||||||
Storage | 2-8°C | ||||||
Calibration | 2/6 Points | ||||||
Certification | CE, ISO13485,FSC |